Internal Medicine · Berkeley, CA
NPI
1659503290
Since 2009
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1510 4th St, Suite 1
Berkeley, CA, 94710
Phone (510) 525-8980
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$250K
4,591 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Maria C Rojas D'Croz prescribed most often to Medicare patients was Atorvastatin Calcium, with 417 prescriptions and refills. In total Maria C Rojas D'Croz wrote 4,591 Medicare prescriptions that cost $250K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-02-11.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Atorvastatin Calcium Generic | 417 | 1,312 | 161 | $5,182 |
| Amlodipine Besylate Generic | 200 | 574 | 79 | $2,249 |
| Lisinopril Generic | 143 | 448 | 59 | $1,661 |
| Fluticasone Propionate Generic | 127 | 131 | 55 | $2,453 |
| Metformin Hcl Er Metformin Hcl | 126 | 413 | 56 | $1,150 |
| Losartan Potassium Generic | 126 | 411 | 53 | $1,443 |
| Levothyroxine Sodium Generic | 110 | 328 | 39 | $1,944 |
| Omeprazole Generic | 99 | 185 | 51 | $1,061 |
| Atenolol Generic | 99 | 302 | 38 | $1,089 |
| Simvastatin Generic | 98 | 325 | 43 | $1,140 |
| Jardiance Empagliflozin | 90 | 297 | 37 | $62K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 88 | 88 | 62 | $1,469 |
| Gabapentin Generic | 84 | 231 | 40 | $2,250 |
| Tamsulosin Hcl Generic | 82 | 266 | 41 | $1,477 |
| Famotidine Generic | 79 | 241 | 41 | $928 |
Brand drugs: 466 claims; generic drugs: 4,058 claims; opioid claims: 171.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Maria C Rojas D'Croz were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.